← All patents

US9701758B2

Anti-CD19 scFv (FMC63) polypeptide

University of Texas System

Abstract

Provided are monoclonal antibodies that detect CD 19 CAR-modified immune cells and CAR-modified immune cells irrespective of the tumor associated antigen they target. Methods of using these functional monoclonal antibodies include, but are not limited to, detection, quantification, activation, and …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Laurence J N Cooper
Priority date
May 24, 2013
Filing date
May 23, 2014
Grant date
July 11, 2017
Publication date
July 11, 2017
Language
en
Metadata fetched
August 29, 2026 00:24